课题基金 / 基金详情

Task B24: APP Compound Acquisition and Scaleup

任务 B24：APP 化合物的获取和放大

批准号：

10683811

负责人：

RAYMOND BRONNER

金额：

$235.47万

依托单位：

SOUTHERN RESEARCH INSTITUTE

依托单位国家：

美国

项目类别：

财政年份：

2022

资助国家：

美国

项目状态：

未结题

起止时间：

2022-05-19 至 2025-05-19

来源：

https://reporter.nih.gov/project-details/10683811

关键词：

Chemistry Communicable Diseases Development Development Plans Drug Kinetics Evaluation In Vitro Interventional Agent Development Lead Microbiology RNA Viruses Safety Services Therapeutic Toxicology Toxin in vivo pathogen pre-clinical product development programs therapeutic development

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文